For: | Ahn DW, Jeong JB, Kang J, Kim SH, Kim JW, Kim BG, Lee KL, Oh S, Yoon SH, Park SJ, Lee DH. Fatty liver is an independent risk factor for gallbladder polyps. World J Gastroenterol 2020; 26(44): 6979-6992 [PMID: 33311944 DOI: 10.3748/wjg.v26.i44.6979] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i44/6979.htm |
Number | Citing Articles |
1 |
Lianhua Zhu, Peng Han, Bo Jiang, Nan Li, Ziyu Jiao, Yaqiong Zhu, Wenbo Tang, Xiang Fei. Value of Conventional Ultrasound-based Scoring System in Distinguishing Adenomatous Polyps From Cholesterol Polyps. Journal of Clinical Gastroenterology 2022; 56(10): 895 doi: 10.1097/MCG.0000000000001639
|
2 |
Kun Wang, Qingpeng Xu, Lu Xia, Jianing Sun, Kanger Shen, Haoran Liu, Linning Xu, Rui Li. Gallbladder polypoid lesions: Current practices and future prospects. Chinese Medical Journal 2024; 137(14): 1674 doi: 10.1097/CM9.0000000000003019
|
3 |
Hack-Lyoung Kim, Dong-Won Ahn, Su Hwan Kim, Dong Seok Lee, Soon Ho Yoon, Joo-Hee Zo, Myung-A. Kim, Ji Bong Jeong. Association between body fat parameters and arterial stiffness. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00175-z
|
4 |
Changhao Dong, Rui Xian, Guangxiang Wang, Lihong Cui. Small Intestinal Bacterial Overgrowth in Patients with Gallbladder Polyps: A Cross-Sectional Study. International Journal of General Medicine 2023; : 813 doi: 10.2147/IJGM.S399812
|
5 |
Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim. Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD. Alimentary Pharmacology & Therapeutics 2023; 58(3): 322 doi: 10.1111/apt.17601
|
6 |
Jun-Il Yoo, Jung-Taek Kim, Chan Ho Park, Yonghan Cha. Diagnosis and Management of Sarcopenia after Hip Fracture Surgery: Current Concept Review. Hip & Pelvis 2022; 34(1): 1 doi: 10.5371/hp.2022.34.1.1
|
7 |
Sami Akbulut, Tevfik Tolga Sahin. Comment on gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions. International Journal of Surgery Case Reports 2021; 83: 105947 doi: 10.1016/j.ijscr.2021.105947
|
8 |
Xudong Zhang, Jincheng Wang, Baoqiang Wu, Tao Li, Lei Jin, Yong Wu, Peng Gao, Zhen Zhang, Xihu Qin, Chunfu Zhu. A Nomogram-based Model to Predict Neoplastic Risk for Patients with Gallbladder Polyps. Journal of Clinical and Translational Hepatology 2022; 10(2): 263 doi: 10.14218/JCTH.2021.00078
|
9 |
Xinhe Zhang, Lin Guan, Haoyu Tian, Yiling Li. Prevalence and Risk Factors of Gallbladder Stones and Polyps in Liaoning, China. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.865458
|
10 |
Ijin Joo, Min-Sun Kwak, Dae Hyun Park, Soon Ho Yoon, Clemens Fürnsinn. Fully automated waist circumference measurement on abdominal CT: Comparison with manual measurements and potential value for identifying overweight and obesity as an adjunct output of CT scan. PLOS ONE 2021; 16(7): e0254704 doi: 10.1371/journal.pone.0254704
|
11 |
Nam Hee Kim, Ji Hun Kang, Hong Joo Kim. Impact of nonalcoholic fatty liver disease on the risk of gallbladder polyps in lean and non-obese individuals: A cohort study. Hepatobiliary & Pancreatic Diseases International 2024; 23(6): 573 doi: 10.1016/j.hbpd.2024.01.006
|
12 |
Nam Hee Kim, Hong Joo Kim, Ji Hun Kang. Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study. The Korean Journal of Internal Medicine 2023; 38(6): 844 doi: 10.3904/kjim.2023.197
|
13 |
S. N. Mekhtiev, O. A. Mekhtievа, O. M. Berko. Current perspective on the problem of cholesterol polyps of the gallbladder in patients with nonalcoholic fatty liver disease. Meditsinskiy sovet = Medical Council 2022; (14): 70 doi: 10.21518/2079-701X-2022-16-14-70-78
|
14 |
Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, Takanori Kashihara, Shota Fujmoto, Tomoyuki Kawaguchi, Reiko Yokoyama, Kaizo Kagemoto, Hironori Tanaka, Yoshifumi Kida, Tetsu Tomonari, Yasushi Sato, Masahiko Nakasono, Tetsuji Takayama. Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-73429-1
|
15 |
Su Hwan Kim, Hyoun Woo Kang, Ji Bong Jeong, Dong Seok Lee, Dong-Won Ahn, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Sohee Oh, Soon Ho Yoon, Sang Joon Park, Mauro Lombardo. Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study. PLOS ONE 2021; 16(8): e0256083 doi: 10.1371/journal.pone.0256083
|
16 |
A. O. Bueverov. Hepatobiliary continuum: non-alcoholic fatty liver disease, cholelithiasis ... what else?. Meditsinskiy sovet = Medical Council 2021; (15): 68 doi: 10.21518/2079-701X-2021-15-68-76
|
17 |
Emine Duygu Boz, Refik Demirtunç, Mehmet Sözen. Are metabolic syndrome and its components a risk factor for gallbladder polyps?. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2021; 17(3): 214 doi: 10.22141/2224-0721.17.3.2021.232650
|
18 |
Jing Mao, Shenglian Gan, Shijun Gong, Quan Zhou, Fang Yu, Haifeng Zhou, Huilin Lu, Qian Li, Zhiming Deng. Visceral fat area is more strongly associated with arterial stiffness than abdominal subcutaneous fat area in Chinese patients with type 2 diabetes. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01356-2
|